Skip to content

Press Release · Press Releases

Cambiotics initiates first human clinical trial focused on PFAS reduction in firefighters with occupational PFAS exposure

Issued by PR Newswire

COPENHAGEN, Denmark, Nov. 3, 2026 /PRNewswire/ -- Cambiotics ApS ("Cambiotics"), the company developing beneficial bacteria designed to support the natural elimination of unwanted compounds, such as per- and polyfluoroalkyl substances (PFAS, known as "forever chemicals"), announced today...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

2026 APEC CEO Summit to Be Held in Shenzhen in November

CCPIT: Strong global business interest as summit opens registration across 21 economies SHENZHEN, China, Nov. 5, 2026 /PRNewswire/ -- The 2026 APEC CEO Summit will be held from November 17 to 18 in Shenzhen, China. Hosted by the China Council for the Promotion of International Trade...

PR Newswire ·